Stockreport

InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million

Intercure Ltd.  (INCR) 
US:NASDAQ Investor Relations: investor.incresearch.com/investors
PDF InterCure reports preliminary estimated revenue of NIS 265 million for 2025 and positive Adjusted EBITDA2, marking its twelfth consecutive half-year of positive Adjusted [Read more]